Compound Sodium Alginate Oral Suspension sachet

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Gastro-esophageal Reflux Disease (GERD)

Drug Information

Target Indication

Gastro-esophageal Reflux Disease (GERD)

Clinical Trial

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

HAIAF

Healthcare AI Acquisition Corp.

Related Pipeline

Renal Artery Stenosis

Gastroesophageal Reflux Disease

Pain

Mild Cognitive Impairment